Immune globulin - Biotest

Drug Profile

Immune globulin - Biotest

Alternative Names: BT-595; Human normal immunoglobulin - Biotest

Latest Information Update: 01 Dec 2016

Price : $50

At a glance

  • Originator Biotest Pharmaceuticals
  • Class Immunoglobulins; Immunoproteins; Serum globulins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Immunodeficiency disorders

Most Recent Events

  • 01 Oct 2016 Phase-III clinical trials in Immunodeficiency disorders (In adolescents, In children, In adults, In the elderly) in Hungary (IV) (NCT02810444)
  • 04 Aug 2016 Biotest plans a phase III trial in Immune thrombocytopenic purpura in Germany (NCT02859909)
  • 27 Jun 2016 Preclinical trials in Immunodeficiency disorders in USA (IV) prior to June 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top